Increased Systemic and Local Interleukin 9 Levels in Patients with Carotid and Coronary Atherosclerosis

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Gregersen, Ida ^a,b   Skjelland, Mona ^a   Holm, Sverre ^a   Holven, Kirsten B ^b   Krogh Sørensen, Kirsten ^a   Russell, David ^a,b   Askevold, Erik T ^a,b   Dahl, Christen P ^a,b   Ørn, Stein ^c   Gullestad, Lars ^a,b   Mollnes, Tom E ^a,b,d   Ueland, Thor ^a,b   Aukrust, Pål ^a,b   Halvorsen, Bente ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c STAVANGER UNIVERSITY HOSPITAL   (Norway)

^d NORDLAND HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 9; INTERLEUKIN 9 RECEPTOR; MESSENGER RNA;

ARTICLE; ATHEROGENESIS; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CYTOKINE RELEASE; DISEASE DURATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MAJOR CLINICAL STUDY; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; T LYMPHOCYTE; UNSTABLE ANGINA PECTORIS;

ANTIGENS, CD14; ANTIGENS, CD3; CAROTID ARTERY DISEASES; CAROTID STENOSIS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INTERLEUKIN-17; INTERLEUKIN-9; MALE; MONOCYTES; RECEPTORS, INTERLEUKIN-9;

EID: 84883379072     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072769     Document Type: Article

References (30)

1. Glass CK, Witztum JL, (2001) Atherosclerosis: The Road Ahead. Cell 104: 503-516.
2. Libby P, (2012) Inflammation in Atherosclerosis. Arterioscler Thromb Vasc Biol 32: 2045-2051.
3. Von der Thüsen JH, Kuiper J, Van Berkel TJ, Biessen EA, (2003) Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential. Pharmacol Rev 55: 133-166.
4. Li H, Rostami A, (2009) IL-9: Basic Biology, Signaling Pathways in CD4+ T Cells and Implications for Autoimmunity. J Neuroimmune Pharmacol 5: 198-209.
5. Blom L, Poulsen BC, Jensen BM, Hansen A, Poulsen LK, (2011) IL-33 Induces IL-9 Production in Human CD4+ T Cells and Basophils. PLoS ONE 6: e21695.
6. Gounni AS, Nutku E, Koussih L, Aris F, Louahed J, et al. (2000) IL-9 expression by human eosinophils: regulation by IL-1β and TNF-α. J Allergy Clin Immunol 106: 460-466.
7. Hültner L, Kölsch S, Stassen M, Kaspers U, Kremer JP, et al. (2000) In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9. J Immunol 164: 5556-5563.
8. Zhou LJ, Tedder TF, (1995) A distinct pattern of cytokine gene expression by human CD83+ blood dendritic cells. Blood 86: 3295-3301.
9. Arendse B, van Snick J, Brombacher F, (2005) IL-9 Is a Susceptibility Factor in Leishmania major Infection by Promoting Detrimental Th2/Type 2 Responses. J Immunol 174: 2205-2211.
10. Nowak EC, Weaver CT, Turner H, Begum-Haque S, Becher B, et al. (2009) IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med 206: 1653-1660.
11. Soussi-Gounni A, Kontolemos M, Hamid Q, (2001) Role of IL-9 in the pathophysiology of allergic diseases. J Allergy Clin Immunol 107: 575-582.
12. Yanaba K, Yoshizaki A, Asano Y, Kadono T, Sato S, (2011) Serum interleukin 9 levels are increased in patients with systemic sclerosis: association with lower frequency and severity of pulmonary fibrosis. J Rheumatol 38: 2193-2197.
13. Cappuzzello C, Di Vito L, Melchionna R, Melillo G, Silvestri L, et al. (2011) Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-γ in patients with chronic heart failure. J Transl Med 9: 28.
14. Vistnes M, Wæhre A, Nygård S, Sjaastad I, Andersson KB, et al. (2010) Circulating cytokine levels in mice with heart failure are etiology dependent. J Appl Physiol 108: 1357-1364.
15. Singh TP, Schön MP, Wallbrecht K, Gruber-Wackernagel A, Wang XJ, et al. (2013) Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis. PLoS One 8: e51752.
16. Anderson GB, Ashforth R, Steinke DE, Ferdinandy R, Findlay JM, (2000) CT Angiography for the Detection and Characterization of Carotid Artery Bifurcation Disease. Stroke 31: 2168-2174.
17. Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, et al. (2003) Carotid Artery Stenosis: Gray-Scale and Doppler US Diagnosis: Society of Radiologists in Ultrasound Consensus Conference. Radiology 229: 340-346.
18. Ørn S, Manhenke C, Ueland T, Damås JK, Mollnes TE, et al. (2009) C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction. Eur Heart J 30: 1180-1186.
19. Aukrust P, Aandahl E, Skålhegg B, Nordøy I, Hansson V, et al. (1999) Increased Activation of Protein Kinase A Type I Contributes to the T Cell Deficiency in Common Variable Immunodeficiency. J Immunol 162: 1178-1185.
20. Stylianou E, Aukrust P, Müller F, Nordøy I, Frøland SS, (2001) Complex effects of interferon-alpha on the cytokine network in HIV infection- Possible contribution to immunosuppression. Cytokine 14: 56-62.
21. Abdelilah S, Latifa K, Esra N, Cameron L, Bouchaib L, et al. (2001) Functional expression of IL-9 receptor by human neutrophils from asthmatic donors: role in IL-8 release. J Immunol 166: 2768-2774.
22. Elyaman W, Bradshaw EM, Uyttenhove C, Dardalhon Vr, Awasthi A, et al. (2009) IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc Natl Acad Sci U S A 106: 12885-12890.
23. Pilette C, Ouadrhiri Y, Van Snick J, Renauld J-C, Staquet P, et al. (2002) IL-9 Inhibits Oxidative Burst and TNF-α Release in Lipopolysaccharide-Stimulated Human Monocytes Through TGF-β. J Immunol 168: 4103-4111.
24. Poulin LF, Richard M, Le Moine A, Kiss R, McKenzie AN, et al. (2003) Interleukin-9 promotes eosinophilic rejection of mouse heart allografts. Transplantation 76: 572-577.
25. Ormstad H, Aass HC, Lund-Sørensen N, Amthor KF, Sandvik L, (2011) Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume. J Neurol 258: 677-685.
26. Qi X, Li J, Gu J, Li S, Dang Y, et al. (2003) Plasma levels of IL-8 predict early complications in patients with coronary heart disease after percutaneous coronary intervention. Jpn Heart J 44: 451-461.
27. Ørn S, Breland UM, Mollnes TE, Manhenke C, Dickstein K, et al. (2009) The Chemokine Network in Relation to Infarct Size and Left Ventricular Remodeling Following Acute Myocardial Infarction. Am J Cardiol 104: 1179-1183.
28. Wiener Z, Falus A, Toth S, (2004) IL-9 increases the expression of several cytokines in activated mast cells, while the IL-9-induced IL-9 production is inhibited in mast cells of histamine-free transgenic mice. Cytokine 26: 122-130.
29. Wu B, Huang C, Kato-Maeda M, Hopewell PC, Daley CL, et al. (2008) IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis. Clin Immunol 126: 202-210.
30. Fontaine RH, Cases O, Lelievre V, Mesples B, Renauld JC, et al. (2008) IL-9/IL-9 receptor signaling selectively protects cortical neurons against developmental apoptosis. Cell Death Differ 15: 1542-1552.